Beihai Gofar Chuanshan Biological Balance Sheet Health
Financial Health criteria checks 5/6
Beihai Gofar Chuanshan Biological has a total shareholder equity of CN¥860.0M and total debt of CN¥3.3M, which brings its debt-to-equity ratio to 0.4%. Its total assets and total liabilities are CN¥1.0B and CN¥146.5M respectively.
Key information
0.4%
Debt to equity ratio
CN¥3.34m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥130.09m |
| Equity | CN¥859.98m |
| Total liabilities | CN¥146.52m |
| Total assets | CN¥1.01b |
Recent financial health updates
No updates
Recent updates
Optimistic Investors Push Beihai Gofar Chuanshan Biological Co., Ltd. (SHSE:600538) Shares Up 32% But Growth Is Lacking
Oct 18
Investor Optimism Abounds Beihai Gofar Chuanshan Biological Co., Ltd. (SHSE:600538) But Growth Is Lacking
Jul 12Beihai Gofar Chuanshan Biological Co., Ltd.'s (SHSE:600538) Shares Climb 34% But Its Business Is Yet to Catch Up
Mar 08Financial Position Analysis
Short Term Liabilities: 600538's short term assets (CN¥499.9M) exceed its short term liabilities (CN¥138.6M).
Long Term Liabilities: 600538's short term assets (CN¥499.9M) exceed its long term liabilities (CN¥7.9M).
Debt to Equity History and Analysis
Debt Level: 600538 has more cash than its total debt.
Reducing Debt: 600538's debt to equity ratio has increased from 0% to 0.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 600538 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 600538 has sufficient cash runway for 3 years if free cash flow continues to grow at historical rates of 4.3% each year.